Detalhe da pesquisa
1.
The impact of coding germline variants on contralateral breast cancer risk and survival.
Am J Hum Genet
; 110(3): 475-486, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827971
2.
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
Int J Cancer
; 145(10): 2692-2700, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30927251
3.
Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
Genet Med
; 19(5): 599-603, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27711073
4.
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.
Breast Cancer Res
; 18(1): 98, 2016 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27716369
5.
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.
Hum Mol Genet
; 23(7): 1934-46, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24242184
6.
Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.
Breast Cancer Res Treat
; 158(3): 463-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27438779
7.
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.
Carcinogenesis
; 36(2): 256-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586992
8.
Common germline polymorphisms associated with breast cancer-specific survival.
Breast Cancer Res
; 17: 58, 2015 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897948
9.
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Breast Cancer Res
; 17: 18, 2015 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849327
10.
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma.
Cancer Cell
; 41(6): 1103-1117.e12, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207655
11.
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
NPJ Breast Cancer
; 9(1): 37, 2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173335
12.
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications.
Breast Cancer Res
; 13(5): R90, 2011 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21542898
13.
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome.
Cancers (Basel)
; 13(12)2021 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34200751
14.
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients.
Sci Rep
; 11(1): 14763, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285278
15.
Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.
NPJ Breast Cancer
; 6: 44, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32964118
16.
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases.
Cancers (Basel)
; 12(2)2020 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31991861
17.
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
NPJ Breast Cancer
; 5: 38, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31700994
18.
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
Sci Rep
; 8(1): 6574, 2018 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700408
19.
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Nat Commun
; 9: 16193, 2018 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633761
20.
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.
Oncotarget
; 6(10): 7390-407, 2015 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25823661